Xenin and Related Peptides: Potential Therapeutic Role in Diabetes and Related Metabolic Disorders
Xenin bioactivity and its role in normal physiology has been investigated by several research groups since its discovery in 1992. The 25 amino acid peptide hormone is secreted from the same enteroendocrine K-cells as the incretin hormone glucose-dependent insulinotropic polypeptide (GIP), with early...
Main Authors: | Sarah L Craig, Nigel Irwin, Victor A Gault |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-09-01
|
Series: | Clinical Medicine Insights: Endocrinology and Diabetes |
Online Access: | https://doi.org/10.1177/11795514211043868 |
Similar Items
-
Biological Activity and Antidiabetic Potential of C-Terminal Octapeptide Fragments of the Gut-Derived Hormone Xenin.
by: Christine M Martin, et al.
Published: (2016-01-01) -
Potential Therapeutic Role for Apelin and Related Peptides in Diabetes: An Update
by: Ethan S Palmer, et al.
Published: (2022-02-01) -
Introduction to PC / IX and PC XENIN /
by: 291084 Brown, Peter John
Published: (1985) -
Xenin, a gastrointestinal peptide, regulates feeding independent of the melanocortin signaling pathway
Published: (2009-12-01) -
Therapeutic Potential of Peptides Derived from Animal Venoms: Current Views and Emerging Drugs for Diabetes
by: Aimee Coulter-Parkhill, et al.
Published: (2021-03-01)